期刊文献+

高雄激素和非高雄激素型多囊卵巢综合征患者血清抗苗勒管激素分泌特点及诊断效能比较 被引量:57

Comparisons of Secretive Profile and Diagnostic Power of Anti-Mullerian Hormone in Women with Polycystic Ovaries With and Without Hyperandrogenism
暂未订购
导出
摘要 目的:比较抗苗勒管激素(AMH)在高雄激素和非高雄激素型多囊卵巢综合征(PCOS)患者的分泌特点和诊断效能,对发病机制进行探讨。方法:纳入具有排卵障碍的PCOS患者131例(高雄组62例,非高雄组69例),另外纳入61例输卵管或男方因素不孕的患者为对照组。采用酶联免疫吸附法和化学发光法检测并比较3组患者血清中AMH、性激素、糖脂代谢等生化指标,采用ROC曲线评估AMH对PCOS患者的诊断效能;采用Pearman's相关法分析高雄和非高雄型PCOS患者血清AMH水平与其他各参数间的关系。结果:①PCOS患者血清AMH水平显著高于对照组(P<0.05),高雄组又显著高于非高雄组(P<0.05)。②AMH诊断高雄组PCOS患者的AUC为0.82,敏感性为82%,特异性为64%。AMH诊断非高雄组PCOS患者的AUC为0.66,敏感性为64%,特异性为62%。③高雄组PCOS患者AMH与FSH呈负相关(r=-0.42,P=0.05),与LH呈正相关(r=0.46,P<0.05)。非高雄组PCOS患者AMH与HDL呈负相关(r=-0.28,P<0.05),与BMI、空腹血糖和LDL呈正相关(r=0.26;r=0.27;r=0.29,P<0.05)。结论:AMH适合于诊断某种特定亚型如高雄激素型PCOS,对非高雄激素型PCOS的诊断准确性较低,由此也反映出两种亚型患者发病机制可能存在差异。 Objective:To compare the secretory profiles and diagnostic power of anti-Mullerian hormone (AMH) for the PCOS patient with and without hyperandrogenism. Methods :131 PCOS patients with oligo- menorrhea or amenorrhea(62 for hyperandrogenism ( HA + )and 69 for hyperandrogenism (HA-) were recrui- ted into the study as study group;61 infertility patients because of oviduct factors were included as control group. Pearman's analysis were used to evaluate the relationship between the levels of AMH and basal sexu- al hormones,glucose and lipid metabolic indicators. Results:①The AMH serum levels of PCOS patients were significantly higher than those of control group,with the highest AMH serum level in the HA + group.②The area under curve for predicting PCOS patients in the HA +group was 0. 82, with a sensitivity of 82%, and specificity of 64%. The area under curve for predicting PCOS patients in the HA-group was 0.66,with a sen- sitivity of 64%, and specificity of 62%. ③ln the HA + group, AMH was negatively associated with FSH ( r = - 0. 42, P = 0.05) and positively associated with LH ( r = - 0.46, P 〈 0.05 ). In the HA-group, AMH was negatively associated with HDL( r = -0, 28, P 〈 0.05)and positively associated with BMI ,fasting glucose andLDL(r=0.26;r=0.27;r=0.29,P〈0.05). Conclusions:AMH is only suitable for predicting the PCOS pa- tients with hyperandrogenism. The diagnostic power of AMH is limited when used to predict patients without hyperandrogenism,which to some degree reflects the differences in pathophysiology between the two sub- types.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2014年第2期111-115,共5页 Journal of Practical Obstetrics and Gynecology
基金 国家自然科学基金(编号:81200417) 教育部博士点新教师基金(编号:20120171120093) 广东省自然基金博士启动项目(编号:S2012040007621) 广东省医学科研基金(编号:B201204) 中山大学青年教师培育项目(编号:B002012002) 中山大学孙逸仙纪念医院"逸仙医学人才"培养计划 广州市珠江科技新星专项基金
关键词 多囊卵巢综合征 抗苗勒管激素 高雄激素血症 卵泡发育 Polycystic ovary syndrome Anti-mullerian hormone Hyperandrogenism Folliculogenesis
  • 相关文献

参考文献17

  • 1Visser JA,De Jong FH,Laven JS. Anti-mullerian hormone:a new marker for ovarian function[J].Reproduction,2006,(01):1-9.
  • 2Pellatt L,Hanna L,Brincat M. Granulosa cell production of anti-mullerian hormone is increased in polycystic ovaries[J].Journal of Clinical Endocrinology and Metabolism,2007,(01):240-245.
  • 3Broekmans FJ,Visser JA,Laven JS. Anti-mullerian hormone and ovarian dysfunction[J].Trends in Endocrinology & Metabolism,2008,(09):340-347.
  • 4Pigny P,Jonard S,Robert Y. Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome[J].Journal of Clinical Endocrinology and Metabolism,2006,(03):941-945.
  • 5Li L,Chen X,Mo Y. Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome[J].Wiener klinische Wochenschrift,2010,(17-18):519-524.
  • 6Hart R,Doherty DA,Norman RJ. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome(PCOS)[J].Fertility and Sterility,2010,(03):1118-1121.
  • 7Azziz R,Carmina E,Dewailly D. The androgen excess and PCOS society criteria for the polycystic ovary syndrome:the complete task force report[J].Fertility and Sterility,2009,(02):456-488.
  • 8Pellatt L,Rice S,Mason HD. Anti-mullerian hormone and polycystic ovary syndrome:a mountain too high[J].Reproduction,2010,(05):825-833.
  • 9Piouka A,Farmakiotis D,Katsikis I. Anti-mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity:relationship with increased luteinizing hormone levels[J].American Journal of Physiology Endocrinology and Metabolism,2009,(02):238-243.
  • 10Dewailly D,Pigny P,Soudan B. Reconciling the definitions of polycystic ovary syndrome:the ovarian follicle number and serum anti-mullerian hormone concentrations aggregate with the markers of hyperandrogenism[J].The Journal of Clinical Endocrinology and Metabolism,2010,(09):4399-4405.

同被引文献524

引证文献57

二级引证文献499

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部